CompaniesOtherUpdated Oct 6, 2026
Zenflow
Private. Zenflow is a medical device company developing innovative therapies for the treatment of benign prostatic hyperplasia (BPH).
- Last round
- $52M Series D
- Backed by
- Cook Medical
- Launched
- Not recorded
- People
- 5
Overview
Updated Oct 6, 2026
Every fact carries a numbered source. Where we can't source something, it says so.
Identity fields from the company record are sourced where a source is recorded; those have no number.
Funding
How much has Zenflow raised?
Rounds and backers, each sourced.
Opportunities For accredited investors
Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.
Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.
No live opportunities right now. Accredited investors are notified first when one opens.
Create an accredited profileA vehicle is never smaller than $1,000,000.
People
Who founded and leads Zenflow?
Names and titles only, each sourced.
Sources
Every claim on this page traces to one of these. The numbers match the citations above.
- 1Contact Zenflow | Inquiries About Zenflow Spring opens in a new tabHeadquarters · accessed Oct 6, 2026
- 2About Zenflow | FDA-Approved BPH Treatment Innovation opens in a new tabPeople · accessed Oct 6, 2026
- 3Zenflow Spring® FDA-Approved BPH Treatment | Relief opens in a new tabWebsite · accessed Oct 6, 2026
- 4Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical opens in a new tabStage, Funding · accessed Oct 6, 2026